Why big pharma wants to collect 2 million genomes
For the head of AstraZeneca’s genomics initiative, the challenge is not just getting the sequences, but in putting them to use — wisely.
Send us a link
Can Cuban science go global?
Tensions between Cuba and the United States are easing. But researchers still struggle to join the scientific world.
Is science only for the rich?
Around the world, poverty and social background remain huge barriers in scientific careers.
Mass production of review articles is cause for concern
A torrent of low-quality meta-analyses and systematic reviews in biomedicine might be hiding valuable research and misleading scientists.
Industry is open for business
Postdoc positions in industry can teach people skills that they would not learn in academia.
Tougher rules for clinical-trial transparency
Investigators are now required to disclose all clinical trials, whether successful or not.
Industry is open for business
Postdoc positions in industry can teach people skills that they would not learn in academia.
The office experiment: Can science build the perfect workspace?
Windows, desks and employees are being wired up in a quest to create healthy, evidence-based environments.
Outlook on "Precision Medicine"
A nature Outlook collection of articles on "Precision Medicine"
Europe proposes copyright reform to help scientists mine research papers
Long-awaited plan would exempt computer-aided harvesting from EU copyright law.
Stop ignoring misconduct
Efforts to reduce irreproducibility in research must also tackle the temptation to cheat.
Why scientists must share their research code
'Reproducibility editor' Victoria Stodden explains the growing movement to make code and data available to others
Where are the data?
Papers accepted for publication in Nature and an initial 12 other Nature titles will be required to include information on whether and how others can access the underlying data.
Survey on challenges faced by young scientists
Weâre interested in hearing about the challenges faced by early-career scientists worldwide, especially if you've recently started your own lab, are struggling to maintain a lab, or have left research. We want to hear your stories. Your answers may feature in articles published by Nature's news team.
Go forth and replicate!
To make replication studies more useful, researchers must make more of them, funders must encourage them and journals must publish them.
Replications, ridicule and a recluse
As failures to replicate results using the CRISPR alternative stack up, a quiet scientist stands by his claims.
Betting big on biomedical science
Ambitious bids in the US to map the brain and cure cancer have not boosted overall research funding.
How not to respond to reviewers: Eight simple tips
How not to respond to reviewers: Eight simple tips
Responding to reviewer reports is a key part of publishing academic work in peer reviewed journals. But if you’ve received mixed reviews of a paper or are publishing for the first time, where do you start?
Nature Index Institution outputs
The Nature Index tracks the affiliations of high-quality scientific articles. Updated monthly, the Nature Index presents research outputs by institution and country. Use the Nature Index to interrogate publication patterns and to benchmark research performance.
Legal confusion threatens to slow data science
Researcher who spent months chasing permission to republish online data sets urges others to read up on the law.
The 10 principles of open research data : Scientific Data
The 10 principles of open research data : Scientific Data
With the publication of the Concordat on Open Research Data last week, the UK further cemented its leadership position in promoting access to tax payer-funded research data.
Five cornerstones of a global bioeconomy
Beate El-Chichakli and colleagues outline principles for coordinating bio-based industries to achieve many of the sustainable development goals.
Antibiotics funding splurge gets mixed reception
Multimillion dollar initiative prioritizes drug development over discovery of new molecules.
×